Study number 780511
Dates
Mar 31 2026-Jun 11 2026
Location
Dallas, Texas
Age
18-70
Gender
Males and Females
Smoker
No
Compensation
13,088
Group
3
This is a research study for an investigational drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with type 2 diabetes and other conditions.
Fortrea Dallas, TX is currently recruiting Healthy Adults, ages 18-70
Body Mass Index
Smoking Criteria
Screening procedures
Cohort 3:
Check-in: Mar 31, May 6
Check-out: Apr 8, May 14
Outpatient visit: Apr 15, 22, May 21, 28, Jun 11